Manulife (Manufacturers Life Insurance)
PRPH

Manulife (Manufacturers Life Insurance)’s ProPhase Labs PRPH Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-364
Closed -$6 – 3824
2013
Q4 		$6 Buy
+364
New +$6.55K ﹤0.01% 3475

Other funds holding PRPH

VIP
Vantage Investment Partners Kansas City, Missouri $1.45B AUM 18.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PRPH Position: Q1 2014 in Review

Manulife (Manufacturers Life Insurance) sold out of ProPhase Labs (PRPH) in Q1 2014, closing a stake of 364 shares — an estimated $6 sold.

Manulife (Manufacturers Life Insurance) first reported a position in PRPH in Q4 2013 and held it in 1 quarter. The position peaked at $6 in Q4 2013. 13 funds tracked by Wall St. Rank hold PRPH as of Q1 2014.

  • Manulife (Manufacturers Life Insurance) reported no remaining ProPhase Labs position as of Q1 2014 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 364 ProPhase Labs shares in Q1 2014, an estimated $6.
  • Manulife (Manufacturers Life Insurance) first reported a position in ProPhase Labs in Q4 2013 and held it in 1 quarter.
  • Manulife (Manufacturers Life Insurance)'s ProPhase Labs position peaked at $6 in Q4 2013.
  • 13 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2014.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2014, filed 13 May 2014.